All Type of News
Regulatory Changes Suggested by Local Hospitals
A number of suggestions are brought forth to the government by the domestic association representing the nation's small- and medium-sized medical hospitals, in an effort to assist the hospitals with improved legal and...
Taejoon Introduced New Ethical Products for Ophthalmologic and Gastric Disorders
Taejoon Pharmaceutical has recently made an introduction of new ethical products in two therapeutic areas of retinopathy and gastric ulcer, to be launched in the domestic market under an aggressive marketing promotion...
CJ Launches Domestic Sale of SSI's Tuberculosis Vaccine
CJ Pharmaceutical Division said, effective January 1st, it has launched the domestic sale of BCG Vaccine SSI, under an exclusive distribution agreement made last year with Denmark-based Statens Serum Institute (SSI).A...
New Enteric Nutrition Therapy Products by Fresenius Kabi Korea
Fresenius Kabi Korea recently completed a series of promotional campaigns addressed to the clinical dietitians working at the nation's major general hospitals, by introducing new enteral nutrition products for those p...
Warning on Spread of Norovirus-Borne Gastroenteritis Issued in Japan
Japan's health ministry officials stated on January 11th that the large percentage of people with suspected gastroenteritis infections is caused by norovirus, which has been detected in 1,652 out of total 2,214 people...
Manufacturers Ask for Considerations Towards Small Packaging Requirement
In response to a number of debates and issues surrounding the government's plan to impose the drug small packaging requirement, the pharmaceutical manufacturers are stating that the government should take consideratio...
4,873 Items Subject to Drug Re-Evaluation Reviews
The Korea Food and Drug Administration (KFDA) has released the list of pharmaceutical items subject to this year's re-evaluation reviews on 4,873 items from 4 therapeutic groups with 21 subcategories.
Of the total...
Yuyu's Maxmavil Receives U.S. Patent
Yuyu announced on January 10th that it has received the U.S. patent for Maxmavil, a novel combination anti-osteoporosis drug formulated with alendronate and calcitrol.
Maxmavil is the first novel combination drug b...
Hexal Korea Launches Marketing Activities for Ethical Generics
Hexal Korea, a local subsidiary of Germany's Hexal AG, has recently launched its marketing activities by introducing four pharmaceutical generic products in the domestic market SimvaHexal, LisiHexal, EnaHexal, and Fl...
Clozaril Now Covered by National Health Insurance
Following the last year's approval by the Korea Food and Drug Administration (KFDA) on the additional indication of Clozaril (active ingredient: clozapine) to reduce risk of suicidal behavior in patients with schizoph...
